Similar articles

• Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.

  Hasenfuss G, Gustafsson F, Kaye D, Shah SJ, Burkhoff D, Reymond MC, Komtebedde J, Hünlich M; Reduce LAP-HF Trial Investigators. Hasenfuss G, et al. J Card Fail. 2015 Jul;21(7):594-600. doi: 10.1016/j.cardfail.2015.05.008. Epub 2015 Jun 6. J Card Fail. 2015. PMID: 26055211 Clinical Trial.
• Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).

  Feldman T, Komtebedde J, Burkhoff D, Massaro J, Maurer MS, Leon MB, Kaye D, Silvestry FE, Cleland JG, Kitzman D, Kubo SH, Van Veldhuisen DJ, Kleber F, Trochu JN, Auricchio A, Gustafsson F, Hasenfuβ G, Ponikowski P, Filippatos G, Mauri L, Shah SJ. Feldman T, et al. Circ Heart Fail. 2016 Jul;9(7):e003025. doi: 10.1161/CIRCHEARTFAILURE.116.003025. Circ Heart Fail. 2016. PMID: 27330010 Clinical Trial.
• Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction.

  von Roeder M, Rommel KP, Kowallick JT, Blazek S, Besler C, Fengler K, Lotz J, Hasenfuß G, Lücke C, Gutberlet M, Schuler G, Schuster A, Lurz P. von Roeder M, et al. Circ Cardiovasc Imaging. 2017 Apr;10(4):e005467. doi: 10.1161/CIRCIMAGING.116.005467. Circ Cardiovasc Imaging. 2017. PMID: 28360259
• [InterAtrial Shunt Device in diastolic heart failure].

  Hasenfuß G, Jacobshagen C. Hasenfuß G, et al. Internist (Berl). 2018 Oct;59(10):1054-1062. doi: 10.1007/s00108-018-0484-4. Internist (Berl). 2018. PMID: 30194481 Review. German.
• Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations.

  Chirinos JA. Chirinos JA. J Cardiovasc Transl Res. 2017 Jun;10(3):245-259. doi: 10.1007/s12265-017-9735-3. Epub 2017 Feb 16. J Cardiovasc Transl Res. 2017. PMID: 28210939 Free PMC article. Review.